Trulieve Cannabis (TRLV) Notes Payables (2020 - 2026)

Trulieve Cannabis (TRLV) has reported Notes Payables for 7 consecutive years, with $95.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Notes Payables rose 2645.15% year-over-year to $95.3 million; the TTM figure through Mar 2026 stood at $95.3 million (up 2645.15% YoY), while the FY2025 annual figure was $96.1 million, up 2721.1% from the prior year.
• Notes Payables came in at $95.3 million for Q1 2026 at Trulieve Cannabis, down from $96.1 million in the prior quarter.
• The five-year high for Notes Payables was $121.8 million in Q4 2023, with the low at $3.4 million in Q4 2024.
• Average Notes Payables over 5 years is $54.9 million, with a median of $9.8 million recorded in 2023.
• Across the five-year window, Notes Payables sank 97.2% in 2024 and surged 2721.1% in 2025, its largest moves.
• Year by year, Notes Payables stood at $108.5 million in 2022, then increased by 12.18% to $121.8 million in 2023, then tumbled by 97.2% to $3.4 million in 2024, then soared by 2721.1% to $96.1 million in 2025, then slipped by 0.81% to $95.3 million in 2026.
• According to Business Quant data, Notes Payables over the past three periods registered $95.3 million, $96.1 million, and $112.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.